Changing the face of British Gastroenterology and Hepatology

Leigh Donnelly, Debbie Sharples and Kate Carney

Changing the face of British Gastroenterology and Hepatology

Dr Alenka Brooks

Changing the face of British Gastroenterology and Hepatology

Barbara Bone

Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition

Arasaradnam RP, et al. Gut 2018;0:1–20. doi:10.1136/gutjnl-2017-315909

Changing the face of British Gastroenterology and Hepatology

Angela Green

Changing the face of British Gastroenterology and Hepatology

Maureen Carmichael

Changing the face of British Gastroenterology and Hepatology

Catherine Stansfield

Changing the face of British Gastroenterology and Hepatology

Maggie Vance

Changing the face of British Gastroenterology and Hepatology

Dr Kathy Louise Woolson

Changing the face of British Gastroenterology and Hepatology

Linda Ferris

EUS Survey final few days - don't miss out on winning a £100 Amazon voucher!

This survey is undertaken as part of a PhD study, funded by the Tenovus Cancer Care Charity.

22nd ESGENA Conference

Hosted by the Austrian Society of Endoscopy Nurses and Associates (IVEPA), In Conjunction with the 26th United European Gastroenterology Week in Vienna, Austria

Professor Stephen Attwood on Guidelines on Oesophageal Dilatation in Clinical Practice

A video accompanying the UK Guidelines on Oesophageal Dilatation in Clinical Practice

NIHR Clinician Scientist Award

The NIHR Clinician Scientist Award (NIHR-CS) is a post-doctoral research training fellowship of up to 5 years and is not intended as programme or project grant.

Cancer datasets and tissue pathways

The Royal College of Pathologists

Cancer datasets and tissue pathways

The Royal College of Pathologists

IBD Registry Update: April 2018

Caution about the use of ulipristal acetate (Esmya)

Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.

Now recruiting: Trial of Faecal Microbiota Transplantation (FMT) in Cirrhosis (PROFIT-01)

The primary objective of this study will be to assess whether stabilising gut dysbiosis with FMT in patients with advanced cirrhosis is both feasible and safe.

IBD Registry Appoints First CEO

The IBD Registry Board is delighted to announce the appointment of Liz Dobson as the first Chief Executive Officer of IBD Registry Ltd from 16th April 2018.

Loading more...